New product

Daklinza 60 mg (Daclatasvir) 28 tablets

$37,000

DAKLINZA 60 mg

28 pills

Composition:
  • Active ingredient: Daclatasvir 60 mg.

Indications

Daklinza is used to treat hepatitis C virus (HCV) by activating the NS5A inhibitor. It is also used in the treatment the infection of HCV 1 and 3 concurrently with sofosbuvir and with or without ribavirin.

Side effects

The most common side effects of Daklinza include somnolence, rash, headache, fatigue, diarrhea, nausea, anemia, insomnia, and dizziness.

Contraindications

Do not administer Daklinza with medications that induce the P-glycoprotein transporter (P-gp) and cytochrome P450 3A4 (CYP3A4) as they reduce the exposure to and efficacy of Daklinza. Medications that cause this include rifabutin, phenytoin, phenobarbital, carbamazepine, rifampicin, oxcarbazepine, rifapentine, St John’s wort, and systemic dexamethasone.

Manufacturer:

l.r.S Squibb Myers-Bristol, Italy


DELIVERY WORLDWIDE


Also known as: Daclatasvir, Natdac, Daklahep, Dacihep, Daclacure, MyDecla, Dactovin, Hepcdac, Hepcvir, MyDacla, Daclavirocyrl, Dakvir, HepCfix

Accessories

30 other products in the same category: